Join

Compare · SLP vs TWTR

SLP vs TWTR

Side-by-side comparison of Simulations Plus Inc. (SLP) and Twitter Inc. (TWTR): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both SLP and TWTR operate in EDP Services (Technology), so they compete in similar markets.
  • TWTR is the larger of the two at $28.20B, about 87.9x SLP ($320.9M).
  • SLP has hit the wire 3 times in the past 4 weeks while TWTR has been quiet.
  • TWTR has more recent analyst coverage (25 ratings vs 10 for SLP).
MetricSLPTWTR
Company
Simulations Plus Inc.
Twitter Inc.
Price
-
-
Market cap
$320.9M
$28.20B
1M return
-1.09%
-
1Y return
-41.97%
-
Industry
EDP Services
EDP Services
Exchange
NASDAQ
NYSE
IPO
2013
News (4w)
3
0
Recent ratings
10
25
SLP

Simulations Plus Inc.

Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for noncompartmental analysis and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers KIWI, a cloud-based web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; RENAsym for investigating and predicting drug-induced or acute kidney injury; IPFsym, a software tool to treat or cure idiopathic pulmonary fibrosis; and the Monolix Suite, a solution for modeling and simulation. Further, the company provides population modeling and simulation contract research services; and clinical-pharmacology-based consulting services in support of regulatory submissions. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. The company was founded in 1996 and is headquartered in Lancaster, California.

TWTR

Twitter Inc.

Twitter, Inc. operates as a platform for public self-expression and conversation in real time United States, Japan, and internationally. The company offers Twitter, a platform that allows users to consume, create, distribute, and discover content. It also provides promoted products and services, such as promoted tweets, promoted accounts, and promoted trends, which enable its advertisers to promote their brands, products, and services. In addition, the company offers MoPub, a mobile-focused advertising exchange that combines ad serving, ad network mediation, and a real-time bidding exchange into one monetization platform; Twitter Audience platform, an advertising offering that enables advertisers to extend advertising campaigns; Developer and Enterprise solutions, a software-as-a-service platform that enables developers to build products on Twitter; and paid enterprise access for its public data streams. Twitter, Inc. was founded in 2006 and is headquartered in San Francisco, California.

Latest SLP

Latest TWTR